Cargando…
Cost-effectiveness of apixaban vs. current standard of care for stroke prevention in patients with atrial fibrillation
AIMS: Warfarin, a vitamin K antagonist (VKA), has been the standard of care for stroke prevention in patients with atrial fibrillation (AF). Aspirin is recommended for low-risk patients and those unsuitable for warfarin. Apixaban is an oral anticoagulant that has demonstrated better efficacy than wa...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4104492/ https://www.ncbi.nlm.nih.gov/pubmed/24513791 http://dx.doi.org/10.1093/eurheartj/ehu006 |